BelShifa
PrivateCompany Overview
BelShifa is a healthtech company that operates a location-based marketplace and mobile application connecting patients with pharmacies for medicine and healthcare product delivery.
Sector
Healthcare & Life Sciences
Verticals
E-commerce, Pharma Supply Chain, Patient Engagement
Business Model
B2B2C
Customer Profile
Marketplace Commission, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BelShifa Comparables
Compare BelShifa with similar companies based on industry and business-model similarity.
BelShifa Funding Rounds
Historical fundraising activity
BelShifa Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BelShifa's valuation, stock price, and market status.
Is BelShifa a public or private company?
BelShifa is a private company.
What is the current stock price of BelShifa?
BelShifa is a private company, so its shares have no public market price. Caplight tracks BelShifa's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BelShifa worth (valuation)?
Valuation information for BelShifa is not publicly available.
Can I buy BelShifa stock?
BelShifa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BelShifa's last funding round?
Funding round information for BelShifa is not publicly available.
Who are the main investors in BelShifa?
Investor information for BelShifa is not publicly disclosed.
Will BelShifa IPO soon?
No public IPO plans have been announced for BelShifa.
How can I track BelShifa secondary market activity?
Caplight tracks bids, offers, and trades in BelShifa's shares on secondary markets.